Article
XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jan 2014
Huang Yi, Xie Denghai, Tang Nana, Wang Jishi, Zeng Xiaoqing, Zhao Peng, He Ling
Abstract excerpt
Previous reports implicate XRCC1 Arg399Gln polymorphism as a possible risk factor for several cancers. Increasing studies have been conducted on the association of XRCC1 Arg399Gln polymorphisms with susceptibility to leukemia. However, conflicting results have been generated. The goal of the present study was to derive a more precise estimation of the relationship. Meta-analyses assessing the association of XRCC1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
